Shares in pharmaceutical companies surged yesterday after Johnson & Johnson was ordered to pay $572m in a landmark ruling over their part in the opioid crisis.
Although being handed a large fine, the amount was significantly smaller than the $17billion that the state of Oklahoma had asked for.
After Judge Thad Balkman handed down his ruling shares in J&J rose more than five per cent giving them a $13.5 billion gain, reports CNBC.
Read more of the original article from DailyMail
